Cargando…
Correction: Effectiveness and Safety of Once-Weekly Semaglutide in Japanese Patients with Type 2 Diabetes in Treatment Intensification: A Retrospective Observational Single-Center Study
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981821/ https://www.ncbi.nlm.nih.gov/pubmed/36627460 http://dx.doi.org/10.1007/s13300-022-01365-2 |
| _version_ | 1784900191663423488 |
|---|---|
| author | Yamada, Hodaka Yoshida, Masashi Suzuki, Daisuke Funazaki, Shunsuke Nagashima, Shuichi Masahiko, Kimura Kiyoshi, Otsuka Hara, Kazuo |
| author_facet | Yamada, Hodaka Yoshida, Masashi Suzuki, Daisuke Funazaki, Shunsuke Nagashima, Shuichi Masahiko, Kimura Kiyoshi, Otsuka Hara, Kazuo |
| author_sort | Yamada, Hodaka |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9981821 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99818212023-03-04 Correction: Effectiveness and Safety of Once-Weekly Semaglutide in Japanese Patients with Type 2 Diabetes in Treatment Intensification: A Retrospective Observational Single-Center Study Yamada, Hodaka Yoshida, Masashi Suzuki, Daisuke Funazaki, Shunsuke Nagashima, Shuichi Masahiko, Kimura Kiyoshi, Otsuka Hara, Kazuo Diabetes Ther Correction Springer Healthcare 2023-01-11 2023-03 /pmc/articles/PMC9981821/ /pubmed/36627460 http://dx.doi.org/10.1007/s13300-022-01365-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Correction Yamada, Hodaka Yoshida, Masashi Suzuki, Daisuke Funazaki, Shunsuke Nagashima, Shuichi Masahiko, Kimura Kiyoshi, Otsuka Hara, Kazuo Correction: Effectiveness and Safety of Once-Weekly Semaglutide in Japanese Patients with Type 2 Diabetes in Treatment Intensification: A Retrospective Observational Single-Center Study |
| title | Correction: Effectiveness and Safety of Once-Weekly Semaglutide in Japanese Patients with Type 2 Diabetes in Treatment Intensification: A Retrospective Observational Single-Center Study |
| title_full | Correction: Effectiveness and Safety of Once-Weekly Semaglutide in Japanese Patients with Type 2 Diabetes in Treatment Intensification: A Retrospective Observational Single-Center Study |
| title_fullStr | Correction: Effectiveness and Safety of Once-Weekly Semaglutide in Japanese Patients with Type 2 Diabetes in Treatment Intensification: A Retrospective Observational Single-Center Study |
| title_full_unstemmed | Correction: Effectiveness and Safety of Once-Weekly Semaglutide in Japanese Patients with Type 2 Diabetes in Treatment Intensification: A Retrospective Observational Single-Center Study |
| title_short | Correction: Effectiveness and Safety of Once-Weekly Semaglutide in Japanese Patients with Type 2 Diabetes in Treatment Intensification: A Retrospective Observational Single-Center Study |
| title_sort | correction: effectiveness and safety of once-weekly semaglutide in japanese patients with type 2 diabetes in treatment intensification: a retrospective observational single-center study |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981821/ https://www.ncbi.nlm.nih.gov/pubmed/36627460 http://dx.doi.org/10.1007/s13300-022-01365-2 |
| work_keys_str_mv | AT yamadahodaka correctioneffectivenessandsafetyofonceweeklysemaglutideinjapanesepatientswithtype2diabetesintreatmentintensificationaretrospectiveobservationalsinglecenterstudy AT yoshidamasashi correctioneffectivenessandsafetyofonceweeklysemaglutideinjapanesepatientswithtype2diabetesintreatmentintensificationaretrospectiveobservationalsinglecenterstudy AT suzukidaisuke correctioneffectivenessandsafetyofonceweeklysemaglutideinjapanesepatientswithtype2diabetesintreatmentintensificationaretrospectiveobservationalsinglecenterstudy AT funazakishunsuke correctioneffectivenessandsafetyofonceweeklysemaglutideinjapanesepatientswithtype2diabetesintreatmentintensificationaretrospectiveobservationalsinglecenterstudy AT nagashimashuichi correctioneffectivenessandsafetyofonceweeklysemaglutideinjapanesepatientswithtype2diabetesintreatmentintensificationaretrospectiveobservationalsinglecenterstudy AT masahikokimura correctioneffectivenessandsafetyofonceweeklysemaglutideinjapanesepatientswithtype2diabetesintreatmentintensificationaretrospectiveobservationalsinglecenterstudy AT kiyoshiotsuka correctioneffectivenessandsafetyofonceweeklysemaglutideinjapanesepatientswithtype2diabetesintreatmentintensificationaretrospectiveobservationalsinglecenterstudy AT harakazuo correctioneffectivenessandsafetyofonceweeklysemaglutideinjapanesepatientswithtype2diabetesintreatmentintensificationaretrospectiveobservationalsinglecenterstudy |